Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has made a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This is a routine compliance filing used by listed companies to inform the stock exchanges about material events or corporate developments. The specific details of what was disclosed are not provided in the available text, so the exact nature of the event (such as a new agreement, acquisition, change in management, or operational update) cannot be determined from the headline alone.
Without the specific content of the disclosure, the direct impact on shareholders or the stock price cannot be assessed. Investors should review the full filing on the NSE/BSE website for details on the underlying material event.